Beneficial effect of acute normovolemic hemodilution in cardiovascular surgery.
OBJECTIVE
The efficacy of acute normovolemic hemodilution (ANH) in avoiding homologous blood transfusion (HBT) during cardiovascular surgery remains controversial. Our objective was to evaluate the impact of ANH on blood transfusion requirements during open cardiovascular surgery using cardiopulmonary bypass (CPB).


METHODS
We retrospectively reviewed 243 patients who had undergone open cardiac or thoracic aortic surgery using CPB between September 2001 and July 2003 in our department. ANH was performed when the hematocrit was over 35% and the patient was hemodynamically stable. Risk factors were selected in accordance with the Japanese Adult Cardiovascular Surgery Database and analyzed to determine their effect on perioperative HBT requirement.


RESULTS
Of the 243 patients, 64 (26%) underwent preoperative autologous blood donation and 62 (26%) ANH. HBT was required in 62% of patients (150/243) overall, in 32% (20/62) of ANH patients, and in 76% (130/171) of non-ANH patients. Multivariate stepwise logistic regression analysis revealed that preoperative or pre-donation hemoglobin value (p < 0.001), duration of surgery (p = 0.001), intraoperative minimum rectal temperature (p = 0.001), age (p = 0.002), need for emergency surgery (p = 0.003), amount of ANH (p = 0.018), blood loss (p = 0.033) and amount of preoperative autologous blood donation (p = 0.042) were independent predictors of the need for perioperative HBT.


CONCLUSIONS
Our data showed that open cardiovascular surgery using CPB continues to pose a high risk of HBT, but that ANH is an effective means of reducing this risk in those patients undergoing these operations.
Taketani
Tsuyoshi
T
Department of Cardiothoracic Surgery, University of Tokyo, Tokyo, Japan.
Motomura
Noboru
N
Toyokawa
Satoshi
S
Kotsuka
Yutaka
Y
Takamoto
Shinichi
S
D000328:Adult; D000368:Aged; D001804:Blood Transfusion, Autologous; D002318:Cardiovascular Diseases / Q000601:surgery*; D013504:Cardiovascular Surgical Procedures / Q000009:adverse effects*; D005260:Female; D006400:Hematocrit; D006438:Hemodilution; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
Anesthesiology. 2002 Feb;96(2):276-82
11818756
Anesthesiology. 2002 Aug;97(2):367-73
12151926
Ann Thorac Surg. 1996 Jul;62(1):130-5
8678631
Anesthesiology. 1999 Jul;91(1):24-33
10422925
Ann Thorac Surg. 1989 Apr;47(4):529-32
2712626
Ann Thorac Surg. 2002 Mar;73(3):739-43; discussion 743-4
11899175
J Thorac Cardiovasc Surg. 1989 Oct;98(4):492-7
2796356
Transfus Med. 1992 Sep;2(3):215-21
1308832
Ann Thorac Surg. 1985 Oct;40(4):380-4
4051620
Ann Thorac Surg. 1992 Dec;54(6):1177-80; discussion 1180-1
1449306
Transfusion. 2001 Mar;41(3):312-5
11274581
Anesthesiology. 2001 Jan;94(1):8-14
11135716
J Thorac Cardiovasc Surg. 1992 May;103(5):1001-6; discussion 1006-7
1569752
Anesthesiology. 1999 Sep;91(3):861-5
10485799
BMJ. 1998 Mar 7;316(7133):717-8
9529394
Ann Thorac Surg. 1999 Dec;68(6):2252-6; discussion 2256-7
10617012
Cardiovasc Surg. 2003 Jun;11(3):201-5
12704329
N Engl J Med. 1990 Aug 2;323(5):315-21
2248640